Neotropix Begins Enrollment in Phase II Trial for Small Cell Lung Cancer

A clinical trial for patients with extensive stage small cell lung cancer is currently enrolling patients in a Phase II clinical trial at the North Central Cancer Treatment Group.
Earth Times